Related Experiment Video
Updated: Aug 10, 2026
17:13
Non-invasive Imaging of Acute Allograft Rejection after Rat Renal Transplantation Using 18F-FDG PET
Published on: April 28, 2013
Thyroid hormone levels in acute renal failure
I Hronek1, B Hronková, A Davenport
1Southmead Hospital, Bristol, United Kingdom.
Renal Failure
|January 1, 1993
Summary
Thyroid hormone levels, including free T3, total T3, free T4, and total T4, are significantly reduced in patients with acute renal failure (ARF). The decrease in total T3 correlates with elevated plasma creatinine levels in early ARF.
Area of Science:
- Endocrinology
- Nephrology
- Clinical Chemistry
Background:
- Acute renal failure (ARF) can impact various physiological systems.
- Thyroid hormone metabolism is complex and may be affected by kidney function.
- Understanding thyroid hormone status in ARF is crucial for patient management.
Purpose of the Study:
- To investigate plasma concentrations of thyroid hormones in patients with ARF.
- To determine the relationship between thyroid hormone levels and renal function markers.
- To assess the early phase changes in thyroid hormone profiles during ARF.
Main Methods:
- Plasma concentrations of free T3, total T3, free T4, total T4, TSH, and TBG were measured in 27 ARF patients.
- Comparison of hormone levels with established normal ranges.
- Correlation analysis between plasma creatinine and thyroid hormone levels.
Main Results:
- Reduced plasma concentrations of free T3, total T3, free T4, and total T4 were observed in ARF patients.
- A weak correlation was found between plasma creatinine and total T3 levels (r = 0.38, p = 0.049).
- No significant differences in plasma TSH or TBG levels were noted between ARF patients and controls.
Conclusions:
- Patients in the early stages of ARF exhibit reduced plasma concentrations of both free and total thyroid hormones (T3 and T4).
- The reduction in total T3 is dependent on the plasma creatinine level, indicating a link between renal function and thyroid hormone status.
- Thyroid hormone assessment may provide insights into the pathophysiology of ARF.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
01:22Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
01:20Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...